Stock ADXN ADDEX THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
0.1155 CHF +0.43% Intraday chart for Addex Therapeutics Ltd -23.26% +151.09%
Apr. 24 Top Premarket Decliners MT
Apr. 18 Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy
MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate
DJ
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate
CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating
MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating
MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target
MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM
GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADXN Stock
  4. News Addex Therapeutics Ltd
  5. Analyst Reco.